Menemşe Gümüşderelioğlu

Prof. Menemşe Gümüşderelioğlu


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2017 in Biofabrication
Verified
Journal Article
Closed access
PDF file
TDTuğrul Tolga Demirtaş
Tuğrul Tolga Demirtaş
GIGülseren Irmak
Gülseren Irmak
MGMenemşe Gümüşderelioğlu
Menemşe Gümüşderelioğlu
Bioprinting can be defined as 3D patterning of living cells and other biologics by filling and assembling them using a computer-aided layer-by-layer deposition approach to fabricate living tissue and organ analogs for tissue engineering. The presence of cells within the ink to use a ‘bio-ink’ presents the potential to print 3D structures that can be implanted or printed into damaged/diseased bone tissue to promote highly controlled cell-based regeneration and remineralization of bone. In this study, it was shown for the first time that chitosan solution and its composite with nanostructured bone-like hydroxyapatite (HA) can be mixed with cells and printed successfully. MC3T3-E1 pre-osteoblast cell laden chitosan and chitosan-HA hydrogels, which were printed with the use of an extruder-based bioprinter, were characterized by comparing these hydrogels to alginate and alginate-HA hydrogels. Rheological analysis showed that all groups had viscoelastic properties. It was also shown that under simulated physiological conditions, chitosan and chitosan-HA hydrogels were stable. Also, the viscosity values of the bio-solutions were in an applicable range to be used in 3D bio-printers. Cell viability and proliferation analyses documented that after printing with bio-solutions, cells continued to be viable in all groups. It was observed that cells printed within chitosan-HA composite hydrogel had peak expression levels for early and late stages osteogenic markers. It was concluded that cells within chitosan and chitosan-HA hydrogels had mineralized and differentiated osteogenically after 21 days of culture. It was also discovered that chitosan is superior to alginate, which is the most widely used solution preferred in bioprinting systems, in terms of cell proliferation and differentiation. Thus, applicability and printability of chitosan as a bio-printing solution were clearly demonstrated. Furthermore, it was proven that the presence of bone-like nanostructured HA in alginate and chitosan hydrogels improved cell viability, proliferation and osteogenic differentiation.

5 May 2007 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
RTR. Seda Tığlı
R. Seda Tığlı
AKAyşe Karakeçili
Ayşe Karakeçili
MGMenemşe Gümüşderelioğlu
Menemşe Gümüşderelioğlu

9 June 2011 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
MGMenemşe Gümüşderelioğlu
Menemşe Gümüşderelioğlu
SDSevcan Dalkıranoğlu
Sevcan Dalkıranoğlu
RAR. Seda Tığlı Aydın
R. Seda Tığlı Aydın
SÇSoner Çakmak
Soner Çakmak

20 April 2009 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
RTR. Seda TıǧlI
R. Seda TıǧlI
SGSourabh Ghosh
Sourabh Ghosh
MLMichael M. Laha
Michael M. Laha
NSNirupama K. Shevde
Nirupama K. Shevde
LDLaurence Daheron
Laurence Daheron
DKDavid Kaplan
David Kaplan
Cartilage tissue can be engineered by starting from a diversity of cell sources, including stem‐cell based and primary cell‐based platforms. Selecting an appropriate cell source for the process of cartilage tissue engineering or repair is critical and challenging, due to the variety of cell options available. In this study, cellular responses of isolated human chondrocytes, human embryonic stem cells and mesenchymal stem cells (MSCs) derived from three sources, human embryonic stem cells, bone marrow and adipose tissue, were assessed for chondrogenic potential in 3D culture. All cell sources were characterized by FACS analysis to compare expression of some surface markers. The cells were differentiated in two different biomaterial matrices, silk and chitosan scaffolds, in the presence and absence of bone morphogenetic protein 6 (BMP6), along with the standard chondrogenic differentiating factors. Embryonic stem cells‐derived MSCs showed unique characteristics, with preserved chondrogenic phenotype in both scaffolds with regard to chondrogenesis, as determined by real time RT‐PCR, histological and microscopical analyses. After 4 weeks of cultivation, embryonic stem cells‐derived MSCs were promising for chondrogenesis, particularly in the silk scaffolds with BMP6. The results suggest that cell source differences are important to consider with regard to chondrogenic outcomes, and among the variables addressed here the human embryonic stem cells‐derived MSCs were the preferred cell source. Copyright © 2009 John Wiley & Sons, Ltd.

1 April 2015 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
TDT. Tolga Demirtaş
T. Tolga Demirtaş
GKGökçe Kaynak
Gökçe Kaynak
MGMenemşe Gümüşderelioğlu
Menemşe Gümüşderelioğlu